Eisenhower Hires First Female Urologist in Desert



prostate 911 walmart :: Article Creator

Prostate Massagers Are Surging In Popularity And The Reason May Surprise You

Prostate massagers are surging in popularity and the reason may surprise you Prostate massagers are surging in popularity and the reason may surprise you

We're living in a golden age of prostate massagers.

Sales of the sex toys, which are designed specifically to stimulate the walnut-sized gland between the root of the penis and the bladder, are surging — and this exploding interest is being driven in large part by what may seem like a surprising source: straight cis men.

"The market for prostate products has been steadily on the rise," says Forrest Andrews, a product developer at Aneros(opens in a new tab), the world's first dedicated prostate massager maker. From 2012 to 2018 alone, their sales doubled. Other retailers have recently reported their sales up by around 40 percent a year.

Thanks in part to this sudden burst of demand, plenty of new competitors in the realm of anal pleasure have emerged, like b-Vibe(opens in a new tab), a butt-centric toy company founded in 2016. A decade ago even a well-stocked and open-minded sex store chain like Babeland only carried one or two prostate-focused toys. Today, they stock almost 30 different models produced by almost a dozen different companies, like the high-end luxury toy maker LELO(opens in a new tab). That company threw its hat into the prostate ring with the BILLY in 2009, just in time to catch what their chief marketing officer Steve Thomson once described to me (a few years back) as "The Great Prostate Rush of 2010, a bona fide run on the anal bank." 

The BILLY massager by LELO.

It's easy to assume that queer consumers are driving this prostate explosion, but that would be a mistake. As the sexologist Carol Queen points out, "our culture tends to conflate anal play and prostate pleasure with gay and bi men," even though not all men who have sex with men engage in anal play. Our culture is also plagued by persistent homophobia(opens in a new tab), which paints any straight man who likes a little anal stimulation as emasculated and twisted. Increased demand for prostate toys within this overarching cultural environment could, one might think, just be a reflection of the increasing visibility of, and social acceptability of marketing content to, people with non-normative sexualities, or of the growing number of men(opens in a new tab) identifying to some degree as queer.

But the reality, explains Coyote Amrich, director of purchasing for all Babeland, Camouflage, and Good Vibrations sex stores, is that "the growth in prostate stimulation and products geared towards the prostate is largely made up of heterosexual cis-gendered men." She's not the only person in the industry who believes this. Leo Debois, founder of the male-focused sex retailer Adam's Toybox, and the teams at Aneros and LELO have all noticed the same trend. "Based upon a number of polls in our user forum and our own internal research," explains Andrews, "we determined our" largely male "customer demographic hovers around 62 percent heterosexual."

How, in a culture with historically little broad knowledge about anal stimulation and so many hang-ups around straight male sexuality, did hetero men end up leading a prostate toy boom?   

Prostate massage usually triggers a uniquely powerful and deep, full-body orgasm in men.

Even through the most severe periods of cultural stigmatization, some straight cis men have found their way to prostate stimulation and gotten hooked on it because prostate massage usually triggers a uniquely powerful and deep, full-body orgasm in men(opens in a new tab). (Andrews has referred to this in the past as The Super O.) Sometimes that orgasm leads to ejaculation. Sometimes it is dry(opens in a new tab). We still don't fully understand all of the mechanics of prostate orgasms, thanks to a dearth of study. (Most research on anal play focuses on health risks. Anal tissue's fragility does make it easier to suffer micro-tears during play and thus, when another person's fluids or unwashed and naked fingers are involved, to transmit diseases.) But for many it can be triggered multiple times in a session.

Many men used to discover this sensation through medicinal prostate massages(opens in a new tab), which doctors prescribed to treat prostatitis, an inflammation of the gland, before the proliferation of antibiotics. Some still recommend men massage their prostates if they have chronic or treatment-resistant prostatitis. This is actually how Aneros got its start. In the late 1990s, its founder sold a medically-oriented massager, called the Pro-State(opens in a new tab), for at-home self-treatment. As Andrews and others started reporting their experiences, Pro-State spun off Aneros in 2002 to serve erotically-minded consumers.

In the late 1980s and early 1990s, Carol Queen recalls, men occasionally came to sex stores on their doctors' orders, seeking toys they could use to stimulate their prostates. But enough were coming in to Good Vibrations in the mid-1990s seeking prostate stimulation for pleasure alone that Queen, who was working there at the time, produced a how-to film, Bend Over Boyfriend, for hetero couples exploring male anal stimulation. By 2001, sex columnist Dan Savage was hearing so much about male anal stimulation among heterosexual couples that he found it necessary to hold a contest to name the act of a woman using a strap-on dildo to have anal sex with her male partner. The winning entry was "pegging," a term which has since spread through pop culture. 

'Bend Over Boyfriend' introduced people to the idea of prostate massage.

FATALE STUDIOS

Men can stimulate their prostates to a degree without anal penetration, by applying pressure to the perineum (the strip of skin between the scrotum and the anus). But many find that does not give them the same thrill or quality of sensation as more direct, internal stimulation. Until Aneros came out with its dedicated prostate massagers, most men interested in non-penile internal prostate stimulation had to use fingers, or toys made for other purposes.

Other toys work to a degree, but their grips and handles and even the bend of a human wrist often aren't ideal for comfort during stimulation. Nor is the curve of the average dildo(opens in a new tab) ideal for hitting the prostate. And dildos and vibrators without a flared base(opens in a new tab) risk getting stuck in a rectum, necessitating a trip to your friendly neighborhood proctologist.

So before 2002, the market for prostate stimulation may have been artificially suppressed by cultural stigmas, a lack of open conversation and knowledge, and also just by a lack of products made and market precisely for it. Aneros did see steady growth in its business from 2002 on, Andrews says — just not on par with the last decade's growth rate. 

The MGX Trident is based on the original Aneros model.

The big spike of the past decade probably had a lot to do with toy makers' outreach and education efforts. Aneros reps travel the world, says Andrews, "giving training sessions on the ins and outs of prostate play, while familiarizing sales staff with our prostate stimulators." LELO(opens in a new tab) has likewise published and promoted a series of how-to guides and normalization and demystification articles and ads, especially since 2015(opens in a new tab), when they decided to double down on the prostate toy market.

"When educators and retailers are matter of fact" about prostate massage, argues Charlie Glickman(opens in a new tab), co-author of 2013's The Ultimate Guide to Prostate Pleasure — itself a major milestone in easily accessible and reliable information on anal play for all audiences — "it destigmatizes anal and prostate pleasure, which makes it more accessible." (The majority of the people buy his book, Glickman has noticed, seem to be heterosexual cis men or their relationship partners.)

The proliferation of large and anonymous, but open-minded, digital communities devoted to exploring male sexuality, health, and masturbation, like Reddit's r/ProstatePlay(opens in a new tab), which boasts 14,600-plus members, help to amplify and proliferate that information beyond sex stores and retail sites as well. 

There are a variety of Snug Plugs offered by b-Vibe.

b-Vibe

This education slowly collided with more liberal attitudes towards sexual exploration and sensation seeping into pop culture around the turn of the decade. Andrews credits the biggest spikes, in 2012 and 2015, to the popularity of 50 Shades of Grey. (The book was published in 2011, then turned into a movie in 2015.) While god awful in every way, it did mainstream a number of sexual practices, even while massively misrepresenting them(opens in a new tab).

Major mainstream TV shows like Broad City(opens in a new tab) have also started to explore male anal stimulation in a non-judgmental way. (Previous shows and movies often played male anal stimulation for homophobic laughs(opens in a new tab).) Today, even supermarket aisle publications like Cosmopolitan(opens in a new tab) openly and enthusiastically talk about prostate massage.  

"There is far more support for wide-ranging sexual exploration than there used to be," says Queen. In today's cultural sphere, "people are encouraging and informing each other" about new acts, tearing down old taboos — even if some, like male anal stimulation stigmas, fall slower than others.

As part of that exploratory spirit, "more men are realizing that sex doesn't only have to be about the penis" for them, says Glickman. "Men's sexuality is just as complex and diverse as women's."  

Most people are always looking for a new plateau of pleasure.

Many men, adds Andrews, "are convinced that they know everything there is to know about achieving an orgasm. Yet they're looking for greater fulfillment." Because most people are always looking for a new plateau of pleasure. That quest, he stresses, alongside education and general social-sexual liberalization, can open men up to entirely new types of personal stimulation.

Traditionally, hetero men have been more likely to explore their sexuality within the context of a relationship, all too often relying on their female partners(opens in a new tab) to introduce them to or buy them sex toys. But more men, the experts I've spoken to broadly agree, are slowly starting to open up to exploring sexuality on their own, and to buying sex toys for purely solo pleasure and edification.

The Vice 2 from Aneros features remote-controlled massaging.

Millennials and Gen Z-ers have actually been slower to take to prostate massage than Baby Boomers and Gen X-ers on the hunt for new types of pleasure, says Andrews. ("Aging male populations," Chad Davis of sex retailer Adam and Eve pointed out to me a few years ago, often suffer from erectile dysfunction and "find prostate stimulation helpful in attaining erections." They are also often just more aware of their prostates, thanks to all the potential prostatic health issues the gland poses as people age.) But younger demographics seem to be coming around now.

This trend of exploration and openness isn't just a socially progressive community phenomenon either. Recent research(opens in a new tab) on evangelical Christian sex advice publications and groups by sociologist Kelsy Burke has found that even a surprising number overtly homophobic and generally socially conservative believers have opened themselves up to exploring hetero prostate stimulation. People, Amrich notes, have an extraordinary cognitive capacity for drawing personal distinctions between prostate play, which they may embrace, and anal stimulation, which they may still find taboo.

Prostate toy offerings have also improved as cultural forces and education have opened more men to the idea of exploring anal stimulation. Beginners can now find exactly the toy(opens in a new tab) they need to feel comfortable, while experts can dive in for designs that fit their specific needs or desires, whether it's a specific girth, type of vibration, or a discreet size so that they can wear a stimulator around in public. 

The Snug Plug 4's packaging makes it look like almost any other minimalist gadget on the market.

b-Vibe

Over the past three years, new designs have really started to flood the market, according to Glickman. It doesn't hurt that, over the last decade, male sex toy makers in general have shifted away from overtly sexual packaging and designs(opens in a new tab), making toys more inconspicuous, so much so that they might not even register as intimate devices to someone unfamiliar with them. (Aneros has been at the forefront of this trend since its early days.) This makes the process of buying a prostate massager much less intimidating for newbies, or those who might still struggle with some stigma.

On top of all of those butt pleasure-boosting forces, prostate massagers were also perfectly positioned to ride the wellness wave(opens in a new tab) that has helped legitimize sex toys for many retailers and consumers in recent years. Manufacturers not only point out the potential benefits prostate massage can have for those with chronic prostatitis, some also claim that prostate stimulation may be able to help ward off prostate cancer, genital pain, and erectile dysfunction. "The positioning that stimulating the prostate is good for your health," argues Amrich, "shifted the conversation, and people became more curious."

Some of these claims are highly speculative or based on weak studies — real dubious reaches. But so are most claims made by wellness outfits like Goop(opens in a new tab), and they still manage to fly just fine with a massive consumer base. 

There's every reason to believe that the 2020s will be another banner decade for prostate play.

Glickman cautions that the sex toy industry and human sexual trends are hard to predict. The bottom could easily fall out of any trend at any given time, but all of the forces that have propelled prostate massagers to newfound prominence in recent years are still active. If anything, there are plenty of straight men whose stigmas about prostate stimulation could still be chipped away by education and pop cultural acceptance of the act, turning them into potential new customers.

There is also still room for design and marketing innovations, says Glickman, which could capture even more men's attention. And of course a celebrity ambassador could do wonders for the concept, although Queen acknowledges that it's harder to get big names to promote a still somewhat stigmatized act than it was to get, say, Bob Dole to talk Viagra(opens in a new tab) even in 1998.

As such, there's every reason to believe that the 2020s will be another banner decade for prostate play. So don't be surprised in the next year or so, if you hear more and more of your self-avowedly heterosexual cis male friends talking about the wonders of prostate massagers.  

  • Written by

    Mark Hay

  • Photos by

    Zlata Ivleva

  • Edited by

    Cassie Murdoch


  • Prostate Cancer Survival Rates: What They Mean

    As cancer diagnoses go, prostate cancer is often a less serious one. Prostate cancer tends to be slow-growing and slow to spread. For many people who get it, prostate cancer is less concerning than other medical conditions they have.

    For these reasons, and possibly because of earlier detection of low-grade prostate cancers, prostate cancer has one of the highest survival rates of any type of cancer.  But that doesn't mean it can't be serious. It's the second leading cause of cancer death among men in the U.S., after lung cancer. 

    Average survival rates vary depending on your age, the stage of your cancer, and how long you've had it. In general, the earlier your cancer is discovered, the better your health outcome is likely to be. 

    Prostate cancer has one of the highest survival rates of any type of cancer. (Photo Credit: The Image Bank/Getty Images)

    After skin cancer, prostate cancer is the most common cancer in men and in people assigned male a birth. About 1 in 8 will be diagnosed with prostate cancer in their lifetime. And these are just the ones who are diagnosed. Among very elderly men who die of other causes, a surprising two-thirds may have prostate cancer that was never diagnosed.

    But only 1 in 36 people who have prostate cancer die from it. That's because most prostate cancers are diagnosed in older people in whom the disease is more likely to be slow-growing and non-aggressive. Most of them eventually pass away from heart disease, stroke, or other causes -- not their prostate cancer.

    Thinking about survival rates for prostate cancer takes a little mental stretching.  Keep in mind that most people are around 70 when diagnosed with prostate cancer. Over, say, 5 years, many will die from other medical problems unrelated to prostate cancer.

    To determine the prostate cancer survival rate, these people are subtracted from the calculations. Counting only those who are left provides what's called the relative survival rate for prostate cancer.

    Taking that into consideration, these are the relative survival rates:

    Localized prostate cancer survival rate.Some92% of all prostate cancers are found when they're in the early stage, called local or regional. "Local" means there's no indication that cancer has spread beyond the prostate. "Regional" means it's spread (metastasized) to nearby lymph nodes or other structures on the body. Almost 100% of those who have local or regional prostate cancer will survive more than 5 years after diagnosis.

    Metastatic prostate cancer survival rate.Fewer people (about 7%) have more advanced prostate cancer at the time of diagnosis. Once prostate cancer has spread beyond the prostate and nearby structures, survival rates fall. "Distant" prostate cancer has moved into farther-away areas of the body, such as the bones, liver, or lungs. Among those with distant prostate cancer, about one-third will survive for 5 years after diagnosis.

    What about survival rates by time since diagnosis? When you group people with all stages of prostate cancer together:

  • The 5-year relative survival rate is almost 100%. That means that 5 years after being diagnosed, the average person with prostate cancer is just about as likely to be alive as someone without the condition. 
  • The 10-year relative survival rate is 98%. Ten years after their prostate cancer diagnosis, they're only 2% less likely to be alive than anyone else. 
  • The relative 15-year survival rate is 95%. The average person with prostate cancer is 5% less likely to still be living than someone who doesn't have it.
  • The older you get, the more likely you are to develop prostate cancer. Here's how often it's diagnosed among those in different age groups:

  • Under 50: 1 in every 456  
  • Age 50-59: 1 in 54
  • Age 60-69: 1 in 19
  • 70 and up: 1 in 11
  • Survival rate by age

    Age also affects prostate cancer survival rates.  According to a CDC report, those under 50 and over 80 have the lowest relative survival rates. Because those under 50 aren't usually tested for prostate cancer, it may be less likely to be diagnosed in younger people until it reaches the later stages. 

    Counting all stages of prostate cancer together, 5-year-relative survival rates by age are:

  • Under 49: 96.7% 

  • 50-54: 97.8%

  • 55-59: 98.4%

  • 60-64: 98.8%

  • 65-69: 99.6%

  • 70-74: 99.5%

  • 75-79: 98.4%

  • 80 and up: 84.6%

  • As with all cancers, doctors use the term "stage" to describe the cancer's characteristics. Prostate cancer is divided into four stages:

  • Stage I: Cancer cells are limited to within the prostate gland, usually in half or less of one side.
  • Stage II: The cancer is still contained within the prostate but is more likely to spread. It may be in the supportive tissue that surrounds the gland. Stages I and II are considered localized.
  • Stage III: Cancer cells have spread beyond the prostate to nearby areas. They may be found in the seminal vesicles, the glands that make semen. Stage III is considered regional.
  • Stage IV: The cancer has moved farther out to areas like the bones, lymph nodes, liver, or lungs. Stage IV, also called metastatic or advanced, is considered distant. 
  • The three main components doctors use to determine stage are known as TNM:

  • T, for tumor, describes the size of the main area of prostate cancer and its spread.
  • N, for nodes, describes whether prostate cancer has spread to any lymph nodes, and how many and in what locations.
  • M, for metastasis, means distant spread of prostate cancer.
  • In terms of survival rates, those with prostate cancer can basically be divided into two groups:

    Stage I-III prostate cancer survival rates

    People with prostate cancer that's localized to the prostate or just nearby have a high long-term survival rate. Their 5-year relative survival rate is 99%, which means they're nearly as likely as someone without prostate to survive for 5 years.

    Stage IV prostate cancer survival rate

    Those whose prostate cancer has spread to distant areas, like their bones, may need more aggressive treatment. Their relative 5-year survival rate is 34%.

    Your race and ethnic background influence your risk for prostate cancer. Black people are more likely to get prostate cancer than those of other races, and tend to get it at younger ages.  It's more common in non-Hispanic white people than in Asian-American, Hispanic, and Latino people. 

    Black people with prostate cancer are also more likely to die from it than those of other races. Some research has found that Black men are nearly 80% more likely to be diagnosed with prostate cancer and more than twice as likely to die from it than white men.

    According to CDC statistics, in 1999-2017 there were:

  • 36.8 prostate cancer deaths in every 100,000 non-Hispanic black males
  • 17.8 deaths per 100,000 non-Hispanic white males
  • 15.4 deaths per 100,000 Hispanic males
  • Experts aren't sure exactly what causes these differences. The causes likely involve a mix of social and biological factors, including:

  • Genetics
  • Lifestyle
  • Access to quality health care, including screening
  • Discrimination and the stresses it causes
  • Cultural mistrust of health care institutions
  •  

    Prostate cancer often grows slowly, so the outlook for people who have it tends to be good. But the average prostate cancer life expectancy varies depending on several factors, including your age, how long you've had the cancer, and especially how far it's spread. The earlier your prostate cancer is discovered, the better your health outcome is likely to be. 

    Is prostate cancer curable? 

    Prostate cancer is often curable if it's diagnosed in its early stages. 

    What is the longest you can live with metastatic prostate cancer?

    The average 5-year survival rate for advanced prostate cancer is 34%, but your outlook depends on your individual case. While there's no cure for advanced prostate cancer, treatment may help relieve your symptoms and extend your life. 

    What is the prognosis for stage IV prostate cancer?The prognosis for advanced cancer depends on many things,  including where the cancer has spread, how fast it's spread, and how well treatments work for you. Your doctor will consider the stage of your cancer as well as your individual situation to determine the best treatment for you. 

    What is the survival rate of recurrent prostate cancer? 

    One study found that, among people whose prostate cancer came back after surgery to remove the prostate (radical prostatectomy), 91% were still alive after 5 years. The survival rate after 10 years was 77%. 

     


    Prostate Cancer News

    July 9, 2024 — A recent study examined data from more than 10,000 patients with 'Biopsy Gleason Grade Group (GGG) 1,' a diagnosis considered to be the lowest grade cancer. Researchers found that even ...

    June 26, 2024 — Transgender women are still at risk for prostate cancer. A new study concludes that current screening guidelines could miss early-stage prostate cancer in transgender women on hormone ...

    June 5, 2024 — As prostate cancer progresses, it becomes increasingly aggressive and can metastasize. In this form, the tumor is difficult to treat, which is reflected in high mortality rates: Worldwide, the ...

    Jan. 23, 2024 — Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug, a multi-institution, Phase 3 clinical trial has ...

    Jan. 23, 2024 — A 10-year follow up study of nearly 2,500 U.S. Men who received prostate cancer treatment will help inform decision making in terms of treatments and side effects for a diverse ...

    Jan. 22, 2024 — Researchers have identified a receptor protein known as CHRM1 as a key player in prostate cancer cells' resistance to docetaxel, a commonly used chemotherapy drug to treat advanced cancer that ...

    Jan. 10, 2024 — Researchers have developed a blood test that can reliably detect neuroendocrine prostate cancer and differentiate it from castration-resistant prostate cancer-adenocarcinoma ...

    Jan. 9, 2024 — More than 65,000 men fall ill with prostate cancer each year in Germany. Twelve thousand of them develop a treatment-resistant form which eventually ends in death. Now, a team of researchers has ...

    Dec. 4, 2023 — Two new studies give insight into how cells use energy to influence the way prostate tumors survive and grow -- advancements that can help explain why some prostate cancers become resistant to ...

    Nov. 9, 2023 — A globe-spanning scientific team has compiled the most comprehensive list of genetic variants associated with prostate cancer risk -- 451 in all -- through a whole-genome analysis that ranks as the ...

    Nov. 8, 2023 — Studies exploring metformin's power to prevent prostate cancer progression have been inconclusive. Research now shows that the drug has promise, but only for specific ...

    Oct. 18, 2023 — Investigators have identified two promising new treatment options for men with recurrent prostate cancer -- both of which helped patients live longer without their disease progressing than the ...

    Aug. 22, 2023 — Using MRI as a screening test alongside PSA density allowed detection of cancers that would have been missed by the blood test alone, according to new ...

    Aug. 15, 2023 — Researchers demonstrate how mathematical modeling combined with dynamic biomarkers can be used to characterize metastatic disease and identify appropriate therapeutic approaches to improve patient ...

    Aug. 14, 2023 — A study uncovers a new mechanism to explain why some prostate tumors switch from a common, treatable form to a more rare and aggressive form of prostate ...

    Aug. 14, 2023 — Patients with localized prostate cancer have a good chance of survival, but mortality rates among those with advanced, metastatic forms of the condition remain high. Until now, the precise mechanism ...

    July 19, 2023 — Three new biomarkers for prostate cancer have been identified to help pinpoint potentially aggressive cases of the disease, which kills 300,000 men each ...

    July 12, 2023 — Prostate cancer is a leading cause of death among American men, and it's resistant to one of the most powerful chemotherapy medications -- cisplatin. Now, researchers have developed the first ...

    Apr. 10, 2023 — A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body, according to a phase 2 ...

    Mar. 16, 2023 — The combination of two oral medications has shown positive results in people with prostate cancer, whose disease has spread to other parts of the body. Compared with XTANDI plus placebo, the ...






    Comments

    Popular posts from this blog

    Q&A

    Sentinel lymph node biopsy: What cancer patients should know

    I Wish I Didn't Need an Oncologist at All, But I'm Thankful for the One ...